Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) C. Soujanya, Vishnu Institute of Pharmaceutical Education and Research, India.
(2) Saravanakumar Kasimedu, Seven Hills College of Pharmacy, India.
(3) Aman Suresh T, Sandip Institute of Pharmaceutical Sciences, India.
Additional Reviewers:
Additional Reviewers: (Comments received after deadline)
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.73/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (C. Soujanya, India) | File 1 | NA
Stage 2 | Peer Review Report_2 (Saravanakumar Kasimedu, India) | File 1 | File 2
Stage 2 | Peer Review Report_3 (Aman Suresh T, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA